
On August 29, 2025, Shanghai SinoUnited Hospital held the inauguration ceremony for the “National Eminent Surgeon Prof. Xinxiang Li Studio”.

Distinguished attendees included Prof. Xinxiang Li, Director, the Second Department of Colorectal Surgery, Fudan University Shanghai Cancer Center, together with representatives from SinoUnited Health - Dr. Kathy Shi, Founder & CEO of SinoUnited Health, President of Shanghai SinoUnited Hospital, Dr. Hua Shen, Medical President, Shanghai SinoUnited Hospital, Co-Chief Medical Officer, and Justin Zhu, Co-Chief Medical Officer attended the event. With the studio’s inauguration, Prof. Xinxiang Li has been appointed as Academic Leader of Colorectal Oncology, Visiting Specialist of Oncology Center, SinoUnited Health. Moving forward, he will collaborate with the SinoUnited Health to enhance the diagnosis and treatment of colorectal tumors, promote subspecialty development, and deliver more precise, patient-centered care.

Bringing National-Level Expertise at SUH: Direct Access to Authoritative Care
In recent years, the morbidity and mortality rates of colorectal cancer have been rising persistently, with its incidence now ranking as the second highest among malignant tumors. Diets high in fat and low in fiber, combined with sedentary office routines and insufficient physical activity—hallmarks of modern lifestyles—have led to colorectal cancer being labeled a “disease of affluence”. At the same time, increased life expectancy has resulted in a growing number of elderly patients over the age of 70, as age remains one of the most significant risk factors for this cancer. What’s particularly alarming is the trend toward younger onset of colorectal cancer in recent years, creating a substantial burden for families and society as a whole. It is clear that the prevention and treatment of colorectal cancer have reached a critically urgent stage.
Faced with this hidden health threat, collaboration between top medical experts and high-quality healthcare providers drew significant attention. Prof. Xinxiang Li is a leading colorectal cancer surgeon in China. With extensive clinical experience in the diagnosis and management of colorectal cancer, he specializes in minimally invasive laparoscopic surgery and comprehensive treatment for colon cancer, ultra-low rectal sphincter-preserving surgery for rectal cancer, and integrated therapy for advanced colorectal cancer. Prof. Li has pioneered and successfully performed tens of thousands of laparoscopic colorectal procedures. He has also completed nearly 1000 da Vinci robotic surgeries, achieving a quality of minimally invasive operation that meets advanced international standards. He routinely introduces and implements new technologies in the diagnosis and treatment of colorectal cancer both domestically and internationally.
Dr. Kathy Shi, Founder & CEO of SinoUnited Health, President of Shanghai SinoUnited Hospital, stated “Prof. Li’s exceptional clinical expertise and global perspective make this collaboration a milestone in the upgrade of our Oncology Center. By bringing a national-level surgeon studio into SinoUnited Health, we are breaking down traditional barriers to doctor access, enabling patients to receive world-class care just within SinoUnited Health. Together, we will combine cutting-edge technology with comprehensive, full-cycle disease management to provide higher-quality and highly individualized treatment.”

Deepening Subspecialty Collaboration and Multidisciplinary Synergy for Comprehensive Patient Care
At the inauguration ceremony of the “National Eminent Surgeon Prof. Xinxiang Li Studio”, SinoUnited Health officially appointed Prof. Li as Academic Leader of Colorectal Oncology, Visiting Specialist of Oncology Center. Prof. Li expressed that his team will fully leverage their professional expertise in the future by regularly conducting clinical activities, patient education, and academic exchanges to enhance the clinical standards for colorectal cancer diagnosis and treatment at SinoUnited Health. This collaboration provides the strongest guarantee for the development of SinoUnited Health’s general surgery department, especially in the field of digestive system oncology.

Supported by the Oncology Center platform, SinoUnited Health and Prof. Li’s team will work together to improve the quality of gastrointestinal surgical oncology, accelerate disciplinary capacity building, and continuously strengthen their capabilities in delivering high-quality healthcare services. Leveraging its robust multi-disciplinary collaboration system, which includes oncology, radiotherapy, dermatology, urology, orthopedics, psychiatry, nutrition, and more, SinoUnited Health will provide systematic management and treatment for colorectal cancer patients, truly achieving comprehensive, patient-centered healthcare protection.

A Fully Upgraded Oncology Center That Solves Real Patient Pain-points
SinoUnited Oncology Center has recently undergone a comprehensive upgrade aiming at eliminating the usual bottlenecks of fragmented workflows, long waits and outdated protocols of oncology treatment.
The re-engineered center offers:
By uniting the upgraded center's capabilities with Prof. Li's renowned expertise, SinoUnited Health is paving the way for its vision of “International Healthcare,China Innovation”. The partnership will continue to explore a new model of high-quality care, ensuring that more patients can obtain cutting-edge, most updated treatment without leaving the country.
